JDM Financial Group’s TriSalus Life Sciences TLSI Stock Holding History

JDM Financial Group’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.12K	Hold	530	–	–	﹤0.01%	297
2025 Q4	$3.7K	Hold	530	–	–	﹤0.01%	226
2025 Q3	$2.46K	Hold	530	–	–	﹤0.01%	262
2025 Q2	$2.89K	Hold	530	–	–	﹤0.01%	241
2025 Q1	$2.93K	Hold	530	–	–	﹤0.01%	234
2024 Q4	$2.65K	Hold	530	–	–	﹤0.01%	248
2024 Q3	$2.44K	Hold	530	–	–	﹤0.01%	240
2024 Q2	$2.93K	Hold	530	–	–	﹤0.01%	211
2024 Q1	$5.17K	Buy	+530	New	+$4.89K	﹤0.01%	182

Other funds holding TLSI

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

JDM Financial Group's TLSI Position: Q1 2026 in Review

JDM Financial Group held its TriSalus Life Sciences (TLSI) position steady in Q1 2026 at 530 shares worth $2.12K. The position accounts for ﹤0.01% of the portfolio, ranked #297.

JDM Financial Group first reported a position in TLSI in Q1 2024 and has held it in 9 quarters since. The position peaked at $5.17K in Q1 2024. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

JDM Financial Group held 530 shares of TriSalus Life Sciences worth $2.12K as of Q1 2026.
JDM Financial Group left its TriSalus Life Sciences share count unchanged in Q1 2026.
TriSalus Life Sciences made up ﹤0.01% of JDM Financial Group's portfolio in Q1 2026, its #297 holding.
JDM Financial Group first reported a position in TriSalus Life Sciences in Q1 2024 and has held it in 9 quarters since.
JDM Financial Group's TriSalus Life Sciences position peaked at $5.17K in Q1 2024.
84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on JDM Financial Group's 13F filing for Q1 2026, filed 21 May 2026.